|
HS Code |
810590 |
| Productname | Emodin-3-Methyl Ether |
| Casnumber | 491-56-1 |
| Molecularformula | C16H12O5 |
| Molecularweight | 284.27 g/mol |
| Appearance | Yellow crystalline powder |
| Meltingpoint | 213-215°C |
| Solubility | Poorly soluble in water, soluble in ethanol and DMSO |
| Synonyms | Physcion; Emodin monomethyl ether |
| Pubchemcid | 10208 |
| Iupacname | 1,8-Dihydroxy-3-methoxy-6-methylanthraquinone |
| Purity | Typically ≥98% |
| Storagetemperature | Store at 2-8°C |
As an accredited Emodin-3-Methyl Ether factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Emodin-3-Methyl Ether, 1g, supplied in a tightly sealed amber glass vial with printed label, stored in protective secondary packaging. |
| Shipping | Emodin-3-Methyl Ether is shipped in secure, airtight containers, compliant with international chemical transport regulations. Packaging ensures protection from moisture, light, and physical damage. Shipping includes detailed labeling and documentation for safe handling. Suitable temperature-controlled options are available if required. Consult Safety Data Sheet (SDS) for additional transport and storage instructions. |
| Storage | Emodin-3-Methyl Ether should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at 2–8°C (refrigerated). Ensure it is kept away from incompatible substances such as strong oxidizing agents. Label the container clearly and follow all standard chemical safety and storage procedures. |
Applications of Emodin-3-Methyl Ether in Industrial ManufacturingEmodin-3-Methyl Ether provides targeted functionality as a specialty anthraquinone derivative, serving controlled roles across several chemical downstream sectors where selectivity, purity, and integration with established process protocols are critical. Below, our technical team outlines its industrially recognized areas of use, as confirmed through customer plant trials and ongoing quality collaboration. 1. Pharmaceutical Intermediates for Small Molecule SynthesisLeading pharmaceutical manufacturers source Emodin-3-Methyl Ether to use as an advanced intermediate during multi-step synthesis of selective anticancer and anti-inflammatory APIs. Our technical supply supports customer pilot validation where traceability (ICH Q7) and impurity management require high consistency across batches. Purification and methylation steps downstream benefit from its stability under both acidic and basic conditions, allowing flexible process sequences with minimum side reactions. Downstream partners typically employ controlled reactivity in both O-demethylation and subsequent aromatic substitution, integrating the intermediate in complex heterocyclic frameworks to achieve targeted molecular scaffolds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Dye and Pigment ManufactureManufacturers of high-grade anthraquinone dyes use Emodin-3-Methyl Ether as a key intermediate in colorant production, particularly for textile and ink applications requiring color stability, specific resonance structures, and lightfastness. The methyl ether function provides enhanced solubility and reproducible conversion to target pigments through oxidation and condensation steps under controlled pH. Downstream processing involves purification and salt formation to achieve required hue and intensity according to application need, as per industrial test dyeing protocols and batch-to-batch QC benchmarking. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Reference Material SupplyAnalytical laboratories and custom certifying agencies order Emodin-3-Methyl Ether for use as a calibration reference in HPLC, TLC, and GC-MS systems, especially for anthraquinone analysis in forensic, environmental, and residue testing. Manufacturing-grade stability and precise documentation (including CoAs and full mass spec spectra) are essential, allowing downstream users to run batch reproducibility, trace organic screening, and impurity tracking. Calibration substances undergo additional purification (typically >98%) and are packaged to prevent cross-contamination per ISO/IEC 17025 laboratory requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Botanical Extract Standardization and Ingredient Quality ControlProducers of botanical extracts and nutraceutical ingredients synthesize or supplement their natural materials using Emodin-3-Methyl Ether to improve assay consistency, calibration of natural product content, and quality certification. Standardization processes require accurately dosed synthetic standards for batch-to-batch verification of rhubarb, Polygonum, or other anthraquinone-bearing materials. Purified raw material from our facility integrates in both direct assay calibration and as a spike recovery marker during product validation workflows conducted to pharmacopeial and industry standards for functional food and herbal medicines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Emodin-3-Methyl Ether prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Decades in fine chemical synthesis allow us to say with confidence: consistent purity and controlled specifications make the difference in every research, pharmaceutical, and specialty application. Emodin-3-Methyl Ether, sometimes called physcion, demonstrates this well. Our approach captures feedback from chemists and formulators who encounter batch-to-batch fluctuation in purity or reproducibility elsewhere. This product grows from a decade of experience with anthraquinone derivatives, and we keep refining every stage, from raw material qualification to final stability testing.
Sourcing rhubarb root extracts or related plant matter may sound straightforward, but uniformity in plant-derived precursors can fluctuate. Over the years, we rebuilt how we isolate, convert, and purify emodin, then introduce the methyl group at position 3 with specific catalysts and under carefully monitored conditions. Moisture and temperature variability during synthesis affect the yield and byproduct profile, which impacts downstream uses like pharmaceutical synthesis. We test for these issues at every checkpoint instead of relying on generic protocols. What customers receive, we’ve checked for residual solvents, heavy metals, and crystal form.
Chemists in drug discovery and pigment research care deeply about the smallest contamination. Based on years of their feedback, we set clear internal standards: minimum purity of 98%, with HPLC and NMR verification for each batch. Our model focuses on a particle size range of 80-120 mesh, and moisture content remains below 0.5%. During custom synthesis projects, customers steadily ask for lower heavy metal content. We keep total heavy metals under 10 ppm, with lead and cadmium at lower limits after special purification runs. Every lot comes with complete spectral data and a breakdown of assay results, not just a COA summary.
The anthraquinone family covers a lot of ground. We produce several analogues, but subtle structural details drive unique applications. Take emodin, chrysophanol, and aloe-emodin—all differ in group placement around the core ring. Adding a methyl group at position 3, as in Emodin-3-Methyl Ether, shifts solubility and reactivity. Researchers point out that this subtle move improves selectivity in semi-synthetic drug synthesis. Pharmaceutical partners describe more robust crystal lattices, which help with formulation stability. In pigment and dye research, the altered electron distribution shifts color properties, which can be measured spectroscopically.
Working with poorly packaged powders wastes time. We solve for clumping, static electricity, and shipping stress by investing in double-seal PE-lined amber bottles. Moisture absorption risk is controlled in every run by closed-system grinding rooms. That means the product does not cake or degrade after a month on the shelf, even in high-humidity labs. Customers let us know when a batch survives a six-month stability test while competing supplies did not. That feedback keeps us committed to airtight, tamper-proof packaging, labeled directly at the point of filling.
As chemical producers, we treat every raw material, solvent, and byproduct as more than a simple line item. Waste minimization for us is a matter of pride. Solvent recovery systems operate with a closed-loop approach, not just minimal compliance. Staff run regular tests for workplace exposure during methylation steps, and all purification waste is tracked. On-site effluent treatment removes over 99% of colorants and residual organic material before wastewater leaves. For shipping, hazard classifications are clearly marked; we make safety data sheets comprehensive, not generic. End users tell us our product causes fewer cross-contamination issues in sensitive workflows—especially in glassware shared between different anthraquinones. These small details matter to scientists looking for trace consistency.
Drug discovery teams choose Emodin-3-Methyl Ether because the O-methyl group resists unwanted hydrolysis. They use it as a scaffold for synthesizing anti-inflammatory and antimicrobial candidates. Our material shows batch-stable melting points, clean Mass Spectrometry signatures, and sharp NMR peaks, which help medicinal chemists spot small impurities. Synthetic organic chemists value the predictable reactivity of our product—no broad melting ranges, ambiguous signals, or unknown peaks after derivatization steps. As a manufacturer, “real” quality starts with feeding the right intermediate at the right time, so we adjust production schedules instead of overstretching reactor time for short-term gain.
Natural product groups and university labs often want Emodin-3-Methyl Ether for standard reference use. They benchmark complex plant extractions using our product as a standard in TLC, HPLC, or UV-Vis analysis. Teachers tell us that clean reference compounds raise student confidence in spectral interpretation. We make sure every purchase arrives with fresh dating and complete traceability back to the synthesis batch records. Spectroscopists regularly ask for powder X-ray diffraction patterns to confirm crystalline form, which we include by request—because being able to cross-check purity, not just rely on a vendor statement, matters most in academic and regulatory labs.
Pharmaceutical and nutraceutical companies pushed us to investigate stability. They want to know if excipients interact, and whether photodegradation could affect shelf life. We performed our own forced degradation studies in ambient and accelerated conditions, under both UV and high humidity. Results showed unchanged purity and minimal color shift after 3 and 6 months, respectively. This lets our partners set expiration dates supported by data, not guesswork. From capsule makers to topical formulation chemists, we listen closely and re-run tests whenever a new application comes along. Our team believes direct feedback drives real-world improvement, and we bank new learning into every subsequent batch.
Many producers focus solely on meeting minimum regulatory requirements. In practice, we go further. Our GC, HPLC, and NMR routine checks detect even minor process changes. If a chromatography trace looks off by more than 0.1%, or if we spot a new low-level impurity in the NMR, production halts. This means slower turnaround but far fewer end-user complaints. A senior QC chemist with over 25 years at our facility points out that “chasing numbers” is just the starting point; understanding what those numbers mean in downstream chemistry builds long-term trust. Every internal audit reviews methods, reagents, and equipment maintenance. Eight out of ten new clients say their decision to stick with us comes from this hands-on vigilance.
A product rarely fits every application perfectly from the start. Few years back, a client found their formulation left residues after solvent evaporation. We modified the crystallization process and filtered product through new equipment, producing cleaner, more workable powder. In another case, a pigment researcher needed a particular color shift. After refining purity levels, the desired spectral properties showed up. Over time, direct discussions with bench chemists, rather than sales brokers, taught us which quality tweaks drive results. Internal R&D teams develop and test variations before full-scale production so that unique uses, including solid dispersions and complex organic syntheses, get matched with the right batch. Our open-door feedback process lets researchers suggest improvements, which get factored into the next cycle.
We learned from early missteps. Inconsistent quality triggers project delays across pharma, pigment, and research labs alike. All batches get a permanent sample stored for five years and retain records for ten. Customers facing regulatory inspections appreciate our willingness to share these files, complete with analytical raw data. EP, USP, and custom specifications are adhered to where possible—and if something does not match published standards, we document the reasons clearly. Instead of obscuring “out-of-spec” cases, we reach out and offer guidance on fit-for-use options. This open record culture defines how we want to be treated by our own suppliers.
Commodity chemical swings often hit suppliers hardest. We keep our costs stable by negotiating long-term contracts with key raw material growers. Changing climate has challenged herb supply in recent years, but we supplement natural sources with synthetic intermediates developed in-house. This helps mitigate price jumps and maintains batch reliability. We explain cost changes directly to long-time customers. No shortcuts in safety or traceability, even during high demand or when competitors push prices low by cutting corners. Our priority rests on sustaining consistent supply and supporting customers when the market gets volatile.
Our company values hearing from customers—from postdocs at university labs to production chemists in pharma startups. Compliments sting less than complaints do. Most improvements over the last decade came from people using our products daily—not from management meetings. We plan to keep adjusting process steps and analytical checks based on this field intelligence. Post-marketing surveillance, especially regarding adverse effects in drug development, feeds into every round of quality review.
We sell Emodin-3-Methyl Ether as the result of rigorous practice, hard-earned expertise, and real discussion with the end-user community. Our company’s reputation stands not on marketing but on predictability, supply chain honesty, and willingness to revise methods when real-world use exposes gaps. Scientific and industrial partners appreciate full transparency into our QC process. Our team stands behind every batch, and we encourage customers to check any detail or raise any concern—because every insight drives the next improvement.
Manufacturing chemicals like Emodin-3-Methyl Ether remains as much a craft as a science. Every client conversation, every instrument trace, and every unexpected result on the bench shapes our process. Quality, traceability, practical support, and environmental responsibility guide each decision we make. As regulatory environments and science evolve, we promise to move with them, never losing sight of our real goal—the trustworthy supply of precise chemical building blocks that researchers and manufacturers depend on.